Page last updated: 2024-12-10

15,16-dihydrobiliverdin ixa

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

15,16-Dihydrobiliverdin ixa, also known as **dihydrobiliverdin IXα**, is a **bilin**, a type of open-chain tetrapyrrole molecule. It is a **reduced form of biliverdin IXα**, a green pigment found in the breakdown of heme, the iron-containing molecule in red blood cells.

Here's why it's important for research:

**1. Potential therapeutic applications:**

* **Antioxidant properties:** Dihydrobiliverdin IXα has been shown to possess antioxidant properties, potentially protecting cells from damage caused by free radicals. This makes it a potential therapeutic target for conditions like oxidative stress and neurodegenerative diseases.
* **Anti-inflammatory effects:** Studies suggest that dihydrobiliverdin IXα has anti-inflammatory properties, potentially contributing to the reduction of inflammation in various diseases.
* **Anti-cancer activity:** There is some preliminary evidence indicating that dihydrobiliverdin IXα might possess anti-cancer properties, potentially impacting cancer cell growth and survival.

**2. Understanding heme metabolism and biliverdin IXα function:**

* **Studying the reduction of biliverdin IXα:** Understanding the enzymatic process that converts biliverdin IXα to dihydrobiliverdin IXα is crucial for comprehending heme metabolism and the role of biliverdin IXα in various physiological processes.
* **Investigating its role in health and disease:** Researching the specific mechanisms of action of dihydrobiliverdin IXα in biological systems can contribute to understanding its role in maintaining health and its potential involvement in disease development.

**3. Developing novel diagnostic tools:**

* **Monitoring heme metabolism:** Due to its close connection with biliverdin IXα, dihydrobiliverdin IXα could be used as a potential biomarker to monitor heme metabolism and identify abnormalities in this process.

**4. Studying the evolution of tetrapyrrole biosynthesis:**

* **Understanding ancestral pigment molecules:** Dihydrobiliverdin IXα serves as a model molecule for studying the evolution of tetrapyrrole biosynthesis, contributing to understanding the origins and development of these important molecules in living organisms.

Overall, 15,16-dihydrobiliverdin IXα holds significant potential for various research areas, ranging from understanding fundamental biological processes to developing novel therapeutic strategies and diagnostic tools. However, more research is required to fully understand its properties and potential applications.

15,16-dihydrobiliverdin IXa: partially reduced intermediate in the formation of phycobilins for biliverdin IXa; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5281957
CHEBI ID181358
CHEBI ID16790
MeSH IDM0194659

Synonyms (7)

Synonym
3-[(2z,5z)-2-[[3-(2-carboxyethyl)-5-[[(2r)-4-ethenyl-3-methyl-5-oxo-1,2-dihydropyrrol-2-yl]methyl]-4-methyl-1h-pyrrol-2-yl]methylidene]-5-[(3-ethenyl-4-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid
CHEBI:181358
8,12-bis(2-carboxyethyl)-3,18-ethenyl-2,7,13,17-tetramethyl-15,16-dihydrobilin-1,19(21h,24h)-dione
CHEBI:16790
137429-14-2
15,16-dihydrobiliverdin ixalpha
15,16-dihydrobiliverdin ixa
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
biladienesCompounds based on a biladiene skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.56 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]